Pharma Industry
- All
- News
- Videos
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
www.ndtv.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
- Tuesday February 3, 2026
- Health | Written by Sambhav Kumar
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
www.ndtv.com
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
- Wednesday January 28, 2026
- Health | Written by NDTV Health Desk, Edited by Shreya Goswami
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
- Friday December 26, 2025
- Health | Indo-Asian News Service
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
www.ndtv.com
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
- Thursday December 18, 2025
- World News | Indo-Asian News Service
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
www.ndtv.com
-
Pharma OTT Release Date: When and Where to Watch it Online?
- Wednesday December 17, 2025
- Written by Gadgets 360 Staff
Pharma is a Malayalam web series directed by P.R. Arun that explores corporate greed and corruption in the pharmaceutical world. The series raises critical questions about ethics, public health, and power, making it one of the most anticipated OTT releases. It is available in various languages: Hindi, Telugu, Kannada, and Tamil.
-
www.gadgets360.com
-
Pharma OTT Release: When, Where to Watch the Malayalam Medical Thriller Web Series
- Saturday December 6, 2025
- Written by Gadgets 360 Staff
The series shows the conspiracy of unethical drug selling in which many high stake people are involved. It is a suspenseful story with lots of twists and turns and it stars with Nivin Pauly and other effective supporting roles.Pharma is an Indian techno-thriller that uncovers the shadowy world of medicine, morality and massive pharmaceutical power.
-
www.gadgets360.com
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
- Sunday November 23, 2025
- Feature | Edited by Ritu Singh
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
www.ndtv.com
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
www.ndtv.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
- Tuesday February 3, 2026
- Health | Written by Sambhav Kumar
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
www.ndtv.com
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
- Wednesday January 28, 2026
- Health | Written by NDTV Health Desk, Edited by Shreya Goswami
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
- Friday December 26, 2025
- Health | Indo-Asian News Service
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
www.ndtv.com
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
- Thursday December 18, 2025
- World News | Indo-Asian News Service
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
www.ndtv.com
-
Pharma OTT Release Date: When and Where to Watch it Online?
- Wednesday December 17, 2025
- Written by Gadgets 360 Staff
Pharma is a Malayalam web series directed by P.R. Arun that explores corporate greed and corruption in the pharmaceutical world. The series raises critical questions about ethics, public health, and power, making it one of the most anticipated OTT releases. It is available in various languages: Hindi, Telugu, Kannada, and Tamil.
-
www.gadgets360.com
-
Pharma OTT Release: When, Where to Watch the Malayalam Medical Thriller Web Series
- Saturday December 6, 2025
- Written by Gadgets 360 Staff
The series shows the conspiracy of unethical drug selling in which many high stake people are involved. It is a suspenseful story with lots of twists and turns and it stars with Nivin Pauly and other effective supporting roles.Pharma is an Indian techno-thriller that uncovers the shadowy world of medicine, morality and massive pharmaceutical power.
-
www.gadgets360.com
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
- Sunday November 23, 2025
- Feature | Edited by Ritu Singh
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
www.ndtv.com